Back

Cardiac troponin-specific autoantibodies cause interference in cardiac troponin detection in two commercial high-sensitivity assays

29 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Beyond cardiac troponins: myocardial ischaemia or injury? Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Sara Simonen

University of Turku, Turku (Finland)

7 More presentations in this session

Presentation thumbnail
Long forms of cardiac troponin T in non-cardiac diseases with frequent troponin T elevations
Doctor S. Knudsen (Herlev, DK)
Abstract Slides
Presentation thumbnail
Cardiac troponin elevations and risk of major adverse cardiovascular events in five non-cardiac diseases
Doctor S. Knudsen (Herlev, DK)
Abstract Slides
Presentation thumbnail
External validation of an artificial intelligence-based electrocardiogram algorithm for early rule-out of acute myocardial infarction in two large European cohorts
Mr A. Champetier (Basel, CH)
Abstract Slides
Presentation thumbnail
The concentration of long cardiac troponin T forms is independent of age and common comorbidities in patients referred for elective open-heart surgery
Ms T. Tuominen (Turku, FI)
Abstract Slides
Presentation thumbnail
Long-term safety and effectiveness of the ESC 0h/1h troponin protocol in routine clinical care
Mr A. Mahmoud (Lund, SE)
Abstract Slides

Access the full session

Session thumbnail
Beyond cardiac troponins: myocardial ischaemia or injury?

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac troponin autoantibodies in breast cancer patients receiving adjuvant cardiotoxic chemotherapy: the PRADA study
20 June 2025
thumbnail
Congress Presentation
False-positive cardiac troponin I values in healthy athletes post COVID-19 Infection: concerning insights from a prospective cohort study
2 September 2024
thumbnail
Congress Presentation
Serial high-sensitivity troponin I measurements to discriminate type 2 from type 1 myocardial infarction
1 September 2019
thumbnail
Congress Presentation
The significance of high sensitive troponin i and left atrial mechanical dispersion in middle-aged patients with atrial fibrillation
12 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources